日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sodium-glucose cotransporter-2 inhibitors in cancer patients with type 2 diabetes and established immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis

钠-葡萄糖协同转运蛋白2抑制剂在合并2型糖尿病和已确诊免疫检查点抑制剂相关心脏毒性的癌症患者中的应用：一项回顾性分析

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2026.1776717
Guo, Ling; Liu, Jing; Gao, Ruipu; Yang, Chunwang; Li, Zhenli; Guan, Zhengkun; Wang, Yansong; Liu, Guang; Ma, Jingtao; Gao, Guangbin
毒理研究
代谢
免疫/内分泌
糖尿病
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparisons of clinical patterns, short- and long-term prognostic outcomes in patients stratified by the severity of microvascular invasion after curative resection for hepatocellular carcinoma

比较肝细胞癌根治性切除术后，根据微血管侵犯严重程度分层的患者的临床模式、短期和长期预后结果

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-026-04229-2
Li, Zhenli; Xu, Lindi; Liu, Xuantong; Zhu, Shuaishuai; Ni, Yuanzhi; Yan, Shixing; Li, Liang; Qi, Xingshun; Zhang, Wei; Tang, Yufu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Ectopic endometrial mesenchymal stem cell-derived exosomal miR-4466 promotes angiogenesis by targeting RUNX1 in adenomyosis

异位子宫内膜间充质干细胞来源的外泌体 miR-4466 通过靶向 RUNX1 促进子宫腺肌症中的血管生成

期刊:Biochemistry and Biophysics Reports
影响因子:2.2
doi:10.1016/j.bbrep.2026.102457
Wang, Jindan; Ni, Yongyan; Sun, Jiali; Qiu, Yingying; Wei, Xinjun; Wang, Bei; Huang, Meihua; Li, Zhenli; Gui, Tao
外泌体
发育与干细胞
RUNX1
干细胞
细胞生物学
血管生成
发表日期：2026
文献求助 收藏

Explore the potential mediating role of plasma metabolites and cytokines in the causal relationship between gut microbiota and the severity of immune-related adverse events: A Mendelian randomization study

探讨血浆代谢物和细胞因子在肠道菌群与免疫相关不良事件严重程度的因果关系中的潜在中介作用：一项孟德尔随机化研究

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000047916
Liu, Sihan; Ma, Jingtao; Li, Zhenli; Li, Mengjia; Wang, Tenghui; Yao, Tiezhu; Liu, Guang
代谢
微生物学
肠道菌群
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models.

靶向间皮素可增强原位胰腺癌小鼠模型中个性化新抗原疫苗诱导的抗肿瘤免疫反应

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202407976
Cai Zhixiong, Li Zhenli, Zhong Wenting, Lin Fangzhou, Dong Xiuqing, Ye Honghao, Guo Yutong, Chen Geng, Yu Xiaoling, Yu Haijun, Tang Ruijing, Liu Xiaolong
肿瘤
胰腺癌
Mouse
肿瘤免疫
发表日期：2025
文献求助 收藏

Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunity

可植入式人工淋巴结能够快速在体内生成和扩增新抗原特异性T细胞，从而增强抗肿瘤免疫力。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013043
Cai, Zhixiong; Lin, Kongying; Dong, Xiuqing; Li, Zhenli; Chen, Geng; Guo, Luobin; Mou, Pan; Chen, Peizhe; Huang, Junjing; Li, Ling; Liu, Xiaolong; Tang, Ruijing; Zeng, Yongyi
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Updating the paradigm of prophylactic abdominal drainage following pancreatoduodenectomy

更新胰十二指肠切除术后预防性腹腔引流的范式

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001973
Li, Zhenli; Zhang, Yibing; Ni, Yuanzhi; Li, Liang; Xu, Lindi; Guo, Yang; Zhu, Shuaishuai; Tang, Yufu
发表日期：2025
文献求助 收藏

Preoperative assessment for the risk of Clavien-Dindo classification ≥ II grade complications after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism

对继发性甲状旁腺功能亢进患者行全甲状旁腺切除术（不进行自体移植）后发生Clavien-Dindo分级≥II级并发症的术前评估

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1705798
Ni, Yuanzhi; Xu, Lindi; Li, Zhenli; Li, Liang; Yan, Shihang; Cheng, Guangming; Wang, Chunhui; Tang, Yufu
发表日期：2025
文献求助 收藏

Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma

肝细胞癌微血管侵犯的分类、预测和治疗的最新进展

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.70746
Li, Zhenli; Xu, Lindi; Zhu, Shuaishuai; Qi, Xingshun; Zhang, Wei; Tang, Yufu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Liver Resection versus Targeted Therapy Plus PD-1 Inhibitors in Hepatocellular Carcinoma with Type I-II Portal Vein Tumor Thrombus: A Comparative Study

肝切除术与靶向治疗联合PD-1抑制剂治疗伴I-II型门静脉癌栓的肝细胞癌的比较研究

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S571169
Li, Liang; Li, Zhenli; Zhang, Yibing; Zhu, Shuaishuai; Ni, Yuanzhi; Xu, Lindi; Yan, Shixing; Tang, Yufu
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏